Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.01 USD | -2.91% | +0.25% | -30.62% |
May. 29 | Transcript : BridgeBio Pharma, Inc. - Special Call | |
May. 28 | UBS Adjusts Price Target on BridgeBio Pharma to $47 From $51, Maintains Buy Rating | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Neutral |
Resistance | 31.04 | 43.89 | 41.06 |
Spread/Res. | -9.76% | -36.18% | -31.78% |
Spread/Supp. | +15.13% | +15.13% | +65.84% |
Support | 24.33 | 24.33 | 16.89 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- BBIO Stock
- Charts BridgeBio Pharma, Inc.